Serum transthyretin before and after starting tafamidis as outcome predictors in ATTR cardiomyopathy

9 May 2026 (10:03 - 10:12)
Organised by: Logo
Congress Presentation Part of: Contemporary biomarkers for diagnosis, monitoring, and prognosis in heart failure Biomarkers HFA Premium Access Heart Failure 2026 Heart Failure Association (HFA)